0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Presidential Address | 
Ashby C. Moncure, MD
Arch Surg. 2001;136(4):376-382. doi:10.1001/archsurg.136.4.376.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Editorial  | 
Cortical Volume Loss and Neurologic Dysfunction in Multiple Sclerosis
Michael K. Racke, MD; Jaime Imitola, MD
JAMA Neurology
Original Investigation  | 
Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis
Allan MacKenzie-Graham, PhD; Florian Kurth, MD, PhD; Yuichiro Itoh, PhD; et al.
JAMA Neurology
Editorial  | 
Alemtuzumab and Multiple Sclerosis Another Note of Caution
Reinhard Hohlfeld, MD; Tania Kümpfel, MD
JAMA Neurology
Observation  | 
Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
Horst Penkert, MD; Claire Delbridge, MD; Nina Wantia, MD; et al.